CHINA MERCHANTS CHINA DIRECT INVESTMENTS LIMITED Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
CHINA MERCHANTS CHINA DIRECT INVESTMENTS LIMITED 招 商 局 中 國 基 金 有 限 公 司(Incorporated in Hong Kong with limited liability)
(Stock Code: 133) BREAKDOWN OF TOTAL ASSETS AS AT 30 SEPTEMBER 2014The following table shows the unaudited figures of a breakdown of total assets of China Merchants
China Direct Investments Limited (the "Company") as at 30 September 2014.
(A) Direct Investments
Listed (Stock
Location of Exchange)/ Carrying Percentage of
Name of projects headquarters Business nature unlisted value total assets
(US$ million) %
Financial Services:
* 1. China Merchants Bank Co., Ltd. Shenzhen, Guangdong
* 2. Industrial Bank Co., Ltd. Fuzhou,
Fujian
Banking Shanghai
Stock Exchange
Banking Shanghai
Stock Exchange
93 14.55
111 17.37
* 3. China Credit Trust Co., Ltd. Beijing Trust management Unlisted 126 19.60
* 4. China Media (Tianjin) Investment
Management Co., Ltd.
Tianjin Fund management Unlisted 1 0.17
Sub-total: 331 51.69
Culture and Media:
*
Private Equity (Shanghai) Centre
(Limited Partnership)
*
*
*
*
*
1
Manufacturing:
* 11. Shenzhen Geesun Automation
Technology Co., Ltd.
* 12. Jiangsu Huaer Quartz Materials
Co., Ltd.
Shenzhen, Guangdong
Yangzhou, Jiangsu
Production equipment for lithium ion batteries High purity
silica crucibles
Unlisted 0 0.01
Unlisted - -
* 13. Liaoning Zhenlong Native Produce
Holding Company Ltd.
Fuxin, Liaoning
Food processing Unlisted 5 0.71
* 14. Hwagain Group Co., Ltd. Nanning,
Guangxi
Printing paper &
tissue paper
Unlisted 6 0.92
Others:
(i) Energy & Resources:
* 15. Wuhan Rixin Technology Co., Ltd.
(ii) Information Technology:
*
Sub-total: 11 1.64
Wuhan, Hubei Solar energy Unlisted 6 0.96
*
*
(ii
*
Co., Ltd.
(iv) Medical & Pharmaceutical:
* 20. Nanjing Sanhome Pharmaceutical
Co., Ltd.
(B) Other Assets
Nanjing, Jiangsu
Pharmaceutical Unlisted 17 2.67
Sub-total: 31 4.88
Total: 542 84.66
Other receivables N/A N/A 5 0.77
Bank balances and cash (including an amount of
US$77.95 million, denominated in RMB)
N/A N/A 93 14.57
Total: 98 15.34
Grand total: 640 100.00
* The Company carries its investments (specifically financial assets) at fair value in accordance with the Hong Kong Financial Reporting Standards. The Company selects appropriate valuation techniques for investments not quoted in an active market. Valuation techniques commonly used by market practitioners are applied, and an independent valuer has been participating in the valuation of certain investments. The values assigned to the investments are estimated with the best information available to the Company.
Note: Reference is made to the Company's announcement dated 29 September 2014 in relation to NTong Technology Co., Ltd. ("NTong"). Although NTong continues its operations, there may discover some other situations that could adversely affect NTong during the course of self financial examination. The Company thus considers that the fair value of its interest in NTong should be reduced to zero until NTong completes its self financial examination and can provide reliable information for value assessment.
2
For and on behalf of
CHINA MERCHANTS CHINA DIRECT INVESTMENTS LIMITED WANG Xiaoding
Director
Hong Kong, 15 October 2014
As at the date hereof, the Executive Directors of the Company are Mr. LI Yinquan, Mr. HONG Xiaoyuan, Mr. CHU Lap Lik, Victor, Mr. WANG Xiaoding and Mr. TSE Yue Kit; the Non-executive Director is Mr. KE Shifeng; and the Independent Non-executive Directors are Mr. LIU Baojie, Mr. ZHU Li, Mr. TSANG Wah Kwong and Dr. LI Fang. In addition, Ms. KAN Ka Yee, Elizabeth is the Alternate Director to Mr. CHU Lap Lik, Victor.
3
|
distributed by
|
